Clinical TrialsSearch results
Number of results: 701
Other
- Phase II study of gemcitabine alone in locally advanced pancreatic cancer: Japan Clinical Oncology Group Study (JCOG 0506)
- pancreatic neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2006-01-19
Other
- Phase II Study of Gemcitabine + S-1 in Elderly Patients With Non-Small Cell Lung Cancer
- non-small cell lung cancer
- National Hospital Organization Lung Cancer Study Group
- 2008-04-01
Other
- Phase II study of gefitinib in untreated advanced non-small cell lung cancer with EGF receptor mutations
- non-small cell lung cancer
- Hokkaido Lung Cancer Clinical Study Group
- 2005-09-12
Other
- Phase II study of FOLFIRI plus Bevacitumab in the treatment of Japanese patients with advanced colorectal cancer.
- Colorectal cancer
- Japan Clinical Cancer Research Organization
- 2008-10-20
Other
- Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
- Metastatic gastric cancer (Advanced or recurrent gastric cancer)
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01
Other
- Phase II study of cord blood transplantation using myeloablative conditioning in adult patiants (C-SHOT 0603)
- Acute leukemia, Chronic myelogenous leukemia, Myelodysplastic syndrome
- Research Grant on Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare
- 2007-10-29
Other
- Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Japanese Pediatric Brain Tumor Consortium
- 2006-12-08
Other
- Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
- Thymoma (excluding thymic carcinoma)
- Japanese Association for Research on the Thymus
- 2006-04-01
Other
- Phase II study of biweekly cetuximab plus irinotecan for unresectable colorectal cancer
- Unresectable colorectal cancer
- Aichi Cancer Center Hospital
- 2009-05-11
Other
- Phase II study of amrubicin for non-small lung cancer after failure of two or three prior chemotherapy regimens
- NSCLC after failure of two or three prior chemotherapy regimes
- Hokkaido Lung Cancer Clinical Study Group
- 2009-08-07